Skip to end of metadata
Go to start of metadata
You are viewing an old version of this page. View the current version.
Compare with Current
View Page History
« Previous
Version 21
Next »
Project Scope This project team will define best practices for ensuring that similar types of adverse events are considered together for purposes of safety analyses. This project will develop efficient standardised processes and analyses that can leverage new technologies. |
Objectives & Deliverables |
---|
White Paper |
Journal Article |
Project Members | Organisation |
---|
Barbara Hendrickson | Abbvie |
Brian Panik | MedAssessment |
Clio Wu | Chinook Therapeutics |
Emily Goren | Seagen |
Hannah Palac | AbbVie |
Mac Gordon | Johnson & Jhonson |
Mika Tsujimoto | Eli Lilly |
Nhi Beasley | FDA |
Peg Fletcher | MedAssessment |
Ramaiah Muvvala | Inductive Quotient |
Rebeka Revis | IQVIA |
Scott Proestel | FDA |
Vaishali Popat | FDA |